Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04110522 · ClinicalTrials.gov registry record · NA
Psoriatic Arthritis D2P Screening
A NA study of Psoriatic Arthritis, sponsored by Jessica Walsh.
- Recruiting
- Registry status
- NA
- Development phase
- 18,000
- Enrollment target
- 2
- Study locations
NCT04110522: Recruiting NA study of Psoriatic Arthritis, sponsored by Jessica Walsh.
NCT04110522 is a NA study of Psoriatic Arthritis that is actively recruiting participants, run by Jessica Walsh. The registered enrollment target is 18,000 participants, above the 478-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (3666% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04110522, a NA study of Psoriatic Arthritis, is actively recruiting participants, sponsored by Jessica Walsh.
- RECRUITING
- Registry status
- NA
- Development phase
- 18,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis. Previously developed screening questionnaires were intended for use in the setting of a doctor's office to assist providers with referral decisions. However, these screening questionnaires are infrequently used in routine practice because of limitations with time and resources. The study will aim to develop a practical screening strategy that does not require involvement from dermatologists (or other non-rheumatology providers) and can systematically reach a broad range of psoriasis patients, including patients not attending dermatology clinics. The researchers hypothesize that disseminating questionnaires directly to patients outside of a clinic setting (direct-to-patient approach) will educate patients about their PsA risk and improve early PsA diagnoses.
Primary Outcome
The percentage of psoriasis patients with a new diagnosis of PsA will be compared between the Experimental Arms and the Control Arm, and compared between the two Experimental Arms (intervention with direct access to rheumatologist and intervention with standard of care referral)
Conditions Studied
Interventions
- OTHER Direct to patient PsA Screening Questionnaire
Study Locations (2)
Pennsylvania
- University of Pennsylvania - Philadelphia
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,000 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT04110522 shows while recruiting
NCT04110522 is an interventional study that assigns participants to a tested intervention. Its 18,000 participants enrollment target places it among the larger protocols in the corpus, above the 478-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (3666% higher).
The record links to 1 condition, with Psoriatic Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Direct to patient PsA Screening Questionnaire is the first listed.
NCT04110522 reports a single indexed study location in Pennsylvania, Utah.
Frequently Asked Questions
What is clinical trial NCT04110522 about?
NCT04110522 is a clinical study titled "Psoriatic Arthritis D2P Screening". The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis. Previously developed screening questionnaires were intended for use in the setting of a doctor's office to assist providers ...
What is the current status of trial NCT04110522?
This trial is currently recruiting. It is a NA study. The enrollment target is 18,000 participants. The study started on 2019-07-22. Estimated completion is 2025-12-31.
What conditions does trial NCT04110522 study?
This clinical trial studies the following conditions: Psoriatic Arthritis.
What interventions are being tested in trial NCT04110522?
The interventions under investigation include: Direct to patient PsA Screening Questionnaire (OTHER).
Who is sponsoring clinical trial NCT04110522?
This trial is sponsored by Jessica Walsh, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04110522 being conducted?
This trial has 2 study locations across Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04110522's enrollment target sits among peer trials
18,000 1st of 48 higher than 48 of 48 other Psoriatic Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psoriatic Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
RECRUITING · NA
-
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
ACTIVE NOT RECRUITING · NA
-
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
ACTIVE NOT RECRUITING · NA
-
Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05513833 · 18,000 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI